
Cheaper and More Effective: New MIT Breakthrough Could Improve Popular Weight Loss Drugs Such As Ozempic
Researchers at MIT have developed a new drug delivery system called “in vivo antibody painting,” which attaches GLP-1 receptor agonists directly to antibodies inside the body, leading to sustained weight loss and blood sugar control in mice at lower doses. …